Lead sponsor

German Diabetes Center

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

1

Active

192

Total enrollment

26

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1

Trials by status

Active, not recruiting
1

Trials led

COMBAT_T2_NASHHbA1c ≤9.5%Ph 4Active, not recruiting192